<DOC>
	<DOC>NCT01283022</DOC>
	<brief_summary>The purpose of this study is to determine the pharmacokinetics (PK) of misoprostol acid for the MVI 200 in women requiring cervical ripening and induction of labor.</brief_summary>
	<brief_title>Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)</brief_title>
	<detailed_description />
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Provide written informed consent; Pregnant women at ≥ 36 weeks 0 days inclusive gestation; Women aged 18 years or older; Candidate for pharmacologic induction of labor; Single, live vertex fetus; Baseline modified Bishop score ≤ 4; Parity ≤ 3 (parity is defined as one or more births live or dead after 24 weeks gestation); Body Mass Index (BMI) ≤ 50 at the time of entry to the study. Women with hemoglobin level &lt; 10.0 grams per deciliter (g/dL) (confirmed within one week of study drug insertion); Women in active labor; Presence of uterine or cervical scar or uterine abnormality e.g., bicornate uterus. Biopsies, including cone biopsy of the cervix, are permitted; Administration of oxytocin or any cervical ripening or labor inducing agents (including mechanical methods) or a tocolytic drug within 7 days prior to enrollment. Magnesium sulfate is permitted if prescribed as treatment for preeclampsia or gestational hypertension; Severe preeclampsia marked by Hemolytic anemia, Elevated Liver enzymes, Low Platelet count (HELLP) syndrome, other endorgan affliction or Central Nervous System (CNS) findings other than mild headache; Fetal malpresentation; Diagnosed congenital anomalies, not including polydactyly; Any evidence of fetal compromise at baseline (e.g., nonreassuring fetal heart rate pattern or meconium staining); Amnioinfusion or other treatment of nonreassuring fetal status at any time prior to the induction attempt; Ruptured membranes ≥ 48 hours prior to the start of treatment; Suspected chorioamnionitis; Fever (oral or aural temperature &gt; 37.5°C); Any condition in which vaginal delivery is contraindicated e.g., placenta previa or any unexplained genital bleeding at any time after 24 weeks during this pregnancy; Known or suspected allergy to misoprostol, other prostaglandins or any of the excipients; Any condition urgently requiring delivery; Unable to comply with the protocol.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Misoprostol Vaginal Insert</keyword>
	<keyword>Induction of labor</keyword>
	<keyword>Cervical Ripening</keyword>
	<keyword>Rate of Cesarean section</keyword>
</DOC>